Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Book
|
![]() |
The Unequal Pandemic: COVID-19 and Health InequalitiesBristol University Press ;Bristol University Press 2021 ;ISBN: 9781447361237 ;ISBN: 1447361237 ;ISBN: 1447361253 ;ISBN: 9781447361251 ;EISBN: 1447361253 ;EISBN: 9781447361244 ;EISBN: 1447361245 ;EISBN: 9781447361251 ;DOI: 10.46692/9781447361251 ;OCLC: 1257077799Full text available |
2 |
Material Type: Book
|
![]() |
COVID-19 in the Environment: Impact, Concerns, and Management of CoronavirusISBN: 0323902723 ;ISBN: 9780323902724 ;EISBN: 9780323902731 ;EISBN: 0323902731 ;DOI: 10.1016/C2020-0-03518-8 ;OCLC: 1269096029Full text available |
3 |
Material Type: Article
|
![]() |
BNT162b vaccines protect rhesus macaques from SARS-CoV-2Nature (London), 2021-04, Vol.592 (7853), p.283-289 [Peer Reviewed Journal]Copyright Nature Publishing Group Apr 8, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03275-y ;PMID: 33524990Full text available |
4 |
Material Type: Article
|
![]() |
Correction: Evolution and consequences of individual responses during the COVID-19 outbreakPloS one, 2023-10, Vol.18 (10), p.e0292775-e0292775 [Peer Reviewed Journal]COPYRIGHT 2023 Public Library of Science ;2023 Abbas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Abbas et al 2023 Abbas et al ;2023 Abbas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0292775Full text available |
5 |
Material Type: Article
|
![]() |
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964Full text available |
6 |
Material Type: Article
|
![]() |
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Nature (London), 2021-05, Vol.593 (7857), p.130-135 [Peer Reviewed Journal]Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03398-2 ;PMID: 33684923Full text available |
7 |
Material Type: Article
|
![]() |
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impactNature reviews. Immunology, 2022-01, Vol.22 (1), p.57-65 [Peer Reviewed Journal]2021. Springer Nature Limited. ;COPYRIGHT 2022 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00662-4 ;PMID: 34876702Full text available |
8 |
Material Type: Article
|
![]() |
Correction: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminatedPloS one, 2022-07, Vol.17 (7), p.e0271154-e0271154 [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;2022 The PLOS ONE Staff 2022 The PLOS ONE Staff ;2022 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0271154 ;PMID: 35789344Full text available |
9 |
Material Type: Article
|
![]() |
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionNature medicine, 2021-11, Vol.27 (11), p.2032-2040 [Peer Reviewed Journal]2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01540-1 ;PMID: 34588689Full text available |
10 |
Material Type: Article
|
![]() |
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity dataThe Lancet (British edition), 2021-05, Vol.397 (10289), p.2043-2046 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01115-6 ;PMID: 33991480Full text available |
11 |
Material Type: Conference Proceeding
|
![]() |
Challenges for COVID-19 Vaccination Delivery and Data Interoperability In Smaller Independent Primary Care PracticesAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4767Full text available |
12 |
Material Type: Conference Proceeding
|
![]() |
Scoping Review of COVID-19 Vaccination Models for RefugeesAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4935Full text available |
13 |
Material Type: Conference Proceeding
|
![]() |
Exploiting administrative claims data through modelling and creativity: Epidemiology of Post Covid SyndromeAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5229Full text available |
14 |
Material Type: Conference Proceeding
|
![]() |
Post-Acute Sequelae of COVID-19: Analysis of Autoantibody Abnormalities and Impact of Pain on Quality of Life and FunctionAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4787Full text available |
15 |
Material Type: Conference Proceeding
|
![]() |
Factors Influencing Parental Intent to Vaccinate Children Against COVID-19 in the United StatesAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4732Full text available |
16 |
Material Type: Conference Proceeding
|
![]() |
Impact of the COVID-19 Pandemic on Attendance at the 18-month-old Developmental Screening VisitAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5503Full text available |
17 |
Material Type: Conference Proceeding
|
![]() |
Primary prevention and screening during the COVID-19 pandemic: Qualitative findings from the BETTER WISE projectAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4973Full text available |
18 |
Material Type: Conference Proceeding
|
![]() |
Diagnostic Phenotypes of Post-Acute Sequelae Following COVID-19 Leveraging the American Family Cohort, PRIME RegistryAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5288Full text available |
19 |
Material Type: Conference Proceeding
|
![]() |
The prevalence of post-COVID conditions in United States primary care practices in the American Family Cohort PRIME RegistryAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5285Full text available |
20 |
Material Type: Conference Proceeding
|
![]() |
COVID-19 case counts, individual immune function and pathogen avoidance motivationAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4840Full text available |